These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2013759)

  • 1. Cerebral metabolic effects of monoamine oxidase inhibition in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine acutely treated monkeys.
    Palombo E; Porrino LJ; Crane AM; Bankiewicz KS; Kopin IJ; Sokoloff L
    J Neurochem; 1991 May; 56(5):1639-46. PubMed ID: 2013759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment.
    Johannessen JN; Chiueh CC; Bacon JP; Garrick NA; Burns RS; Weise VK; Kopin IJ; Parisi JE; Markey SP
    J Neurochem; 1989 Aug; 53(2):582-9. PubMed ID: 2568405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of monoamine oxidase inhibitors and a dopamine uptake blocker on the distribution of 11C-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 11C-MPTP, in the head of the rhesus monkey.
    Hartvig P; Larsson BS; Lindberg BS; Oreland L; Gullberg P; Långström B; Rimland A; Lundqvist H; Malmborg P; Lindquist NG
    Acta Neurol Scand; 1986 Jul; 74(1):10-6. PubMed ID: 3490110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW; Irwin I; Langston EB; Forno LS
    Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
    Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
    J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate.
    Porrino LJ; Burns RS; Crane AM; Palombo E; Kopin IJ; Sokoloff L
    Life Sci; 1987 Apr; 40(17):1657-64. PubMed ID: 3494179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition.
    Lydén-Sokolowski A; Larsson BS; Lindquist NG
    Pharmacol Toxicol; 1988 Aug; 63(2):75-80. PubMed ID: 3141911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.
    Porrino LJ; Burns RS; Crane AM; Palombo E; Kopin IJ; Sokoloff L
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5995-9. PubMed ID: 3497401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP.
    Palombo E; Porrino LJ; Bankiewicz KS; Crane AM; Sokoloff L; Kopin IJ
    J Neurosci; 1990 Mar; 10(3):860-9. PubMed ID: 2319306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of MPTP acutely increases glucose utilization in the substantia nigra of primates.
    Palombo E; Porrino LJ; Bankiewicz KS; Crane AM; Kopin IJ; Sokoloff L
    Brain Res; 1988 Jun; 453(1-2):227-34. PubMed ID: 3261197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Cohen G; Mytilineou C
    Life Sci; 1985 Jan; 36(3):237-42. PubMed ID: 3917526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.
    Heikkila RE; Duvoisin RC; Finberg JP; Youdim MB
    Eur J Pharmacol; 1985 Oct; 116(3):313-7. PubMed ID: 3935467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its metabolite 1-methyl-4-phenylpyridine on acetylcholine synthesis in synaptosomes from rat forebrain.
    Cheeseman AJ; Clark JB
    J Neurochem; 1987 Apr; 48(4):1209-14. PubMed ID: 3102694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice.
    Sundström E; Jonsson G
    Eur J Pharmacol; 1986 Mar; 122(2):275-8. PubMed ID: 3486769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
    Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity.
    Kalaria RN; Mitchell MJ; Harik SI
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3521-5. PubMed ID: 3495000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential time courses of exogenous 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and its metabolite MPP+ in the rat striatum and nucleus accumbens measured using in vivo voltammetry.
    Nakazato T; Akiyama A
    Brain Res; 1998 Nov; 812(1-2):150-6. PubMed ID: 9813295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.